Another hint towards a more inflammatory background in cases after HCT was the reduced expression of FOXP1 (p = 0.027), which is described as negative regulator of immune response [43] and is overexpressed in EBV-negative PTLD [7]. Here, FOXP1 is linked to post-transplant lymphoproliferative disease.